CRISPR/Cas9 and AAV mediated insertion of β2 microglobulin-HLA-G fusion gene protects mesenchymal stromal cells from allogeneic rejection and potentiates the use for off-the-shelf cell therapy
- Resource Type
- Article
- Source
- In
Regenerative Therapy December 2022 21:442-452 - Subject
- Language
- ISSN
- 2352-3204